Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of HSG4112 in overweight and obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HSG4112

Snippet

Sponsor: Glaceum | Conditions: Obesity | Phase 2 | Status: COMPLETED